3-tyr-octreotide has been researched along with lutetium in 3 studies
| Studies (3-tyr-octreotide) | Trials (3-tyr-octreotide) | Recent Studies (post-2010) (3-tyr-octreotide) | Studies (lutetium) | Trials (lutetium) | Recent Studies (post-2010) (lutetium) |
|---|---|---|---|---|---|
| 95 | 2 | 4 | 1,192 | 44 | 844 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakker, WH; Bernard, BF; Breeman, WA; Bugaj, JE; de Jong, M; Erion, J; Krenning, EP; Schaar, M; Schmidt, M; Srinivasan, A; van Gameren, A | 1 |
| Bernard, BF; Breeman, WA; Capello, A; de Jong, M; Konijnenberg, MW; Krenning, EP | 1 |
| Baum, RP; Bitterlich, N; Kluge, AW; Kulkarni, H; Niepsch, K; Schorr-Neufing, U; van Echteld, CJ | 1 |
1 trial(s) available for 3-tyr-octreotide and lutetium
| Article | Year |
|---|---|
[(177)Lu-DOTA](0)-D-Phe(1)-Tyr(3)-Octreotide ((177)Lu-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study.
Topics: Aged; Carcinoma, Neuroendocrine; Female; Humans; Lutetium; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Receptors, Peptide; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
2 other study(ies) available for 3-tyr-octreotide and lutetium
| Article | Year |
|---|---|
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
Topics: Animals; Autoradiography; Chelating Agents; Kidney; Lutetium; Male; Octreotide; Pancreatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rats; Rats, Inbred Lew; Receptors, Somatostatin; Survival Rate; Tissue Distribution | 2001 |
Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Lutetium; Octreotide; Peptides, Cyclic; Radioisotopes; Rats; Receptors, Peptide; Yttrium | 2003 |